The feasibility study of carboplatin plus etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias

Journal of Thoracic Oncology

Volumn 6, Issue 4, 2011, Pages 801-807

  Minegishi, Yuji ^a   Kuribayashi, Hidehiko ^a   Kitamura, Kazuhiro ^a   Mizutani, Hideki ^a   Kosaihira, Seiji ^a   Okano, Tetsuya ^a   Seike, Masahiro ^a   Azuma, Arata ^a   Yoshimura, Akinobu ^a   Kudoh, Shoji ^b   Gemma, Akihiko ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Japan Anti Tuberculosis Association   (Japan)

Author keywords

Acute exacerbation; Chemotherapy; Idiopathic interstitial pneumonias; Idiopathic pulmonary fibrosis; Small cell lung cancer

Indexed keywords

CARBOPLATIN; ETOPOSIDE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DIARRHEA; DRUG EFFICACY; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

EID: 79953028991     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182103d3c     Document Type: Article

References (37)

1. Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. NEngl JMed 2002;346:85-91. (Pubitemid 34438898)
2. Lara PN Jr, Natale R, Crpwley J, et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWAG S0124. J Clin Oncol 2009;27:2530-2535.
3. Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006;24:2038-2043. (Pubitemid 46622112)
4. Okamoto H, Watanabe K, Kunikane H, et al. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 2007;97:162-169. (Pubitemid 47057464)
5. Skarlos DV, Samantas E, Kosmidis P, et al. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small cell lung cancer. A Hellenic Co-operative Oncology Group Study. Ann Oncol 1994;5:601-607. (Pubitemid 24283096)
6. Turner-Warwick M, Lebowits M, Burrows B, et al. Cryptogenic fibro-sing alveolitis and lung cancer. Thorax 1980;35:496-499. (Pubitemid 10039553)
7. Panos RJ, Mortenson RL, Niccoli SA, et al. Clinical deterioration in patients with idiopathic pulmonary fibrosis: caused and assessment. Am JMed 1990;88:396-404. (Pubitemid 20147276)
8. Hubbard R, Venn A, Lewis S, et al. Lung cancer and cryptogenic fibrosing alveolitis. Population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8. (Pubitemid 30055895)
9. Park J, Kim DS, Shim TS, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001;17:1216-1219. (Pubitemid 32717481)
10. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
11. Kawasaki H, Nagai K, Yokose T, et al. Clinicopatological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. Surg Oncol 2001;76:53-57. (Pubitemid 32128363)
12. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathological findings in three cases. Chest 1993;103:1808-1812. (Pubitemid 23174318)
13. Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 1997;168:79-83. (Pubitemid 27014751)
14. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 2003;22: 821-826. (Pubitemid 37369573)
15. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 2005;128:3310-3315. (Pubitemid 41698656)
16. Blivet S, Philit F, Sab JM, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001;120:209-212. (Pubitemid 32744881)
17. Stern JB, Mal H, Groussard O, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest 2001;120:213-219. (Pubitemid 32744882)
18. Koizumi K, Hirata T, Hirai K, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg 2004; 10:340-346.
19. Chiyo M, Sekine Y, Iwata T, et al. Impact ofinterstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outocomes. J Thorac Cardiovasc Surg 2003;126:1141-1146. (Pubitemid 37305703)
20. Watanabe A, Higami T, Ohori S, et al. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thoracic Surg 2008; 136:1357-1363.
21. Chida M, Ono S, Hoshikawa Y, et al. Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery. Eur J Cardiovasc Surg 2008;34: 878-881.
22. Minegishi Y, Sudoh J, Kuribayasi H, et al. The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias. Lung Cancer 2011;71:70-74.
23. Minegishi Y, Takenaka K, Mizutani H, et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Intern Med 2009;48:665-672.
24. Raghu G, Mageto YM, Lockhart D, et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other intersti-tial lung disease: a prospective study. Chest 1999;116:1168-1174. (Pubitemid 29535965)
25. Nishimura K, Kitaichi M, Izumi T, et al. Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 1992;182: 337-342.
26. Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999;211:555-560. (Pubitemid 29206830)
27. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumor. J Natl Cancer Inst 2000;92:205-216. (Pubitemid 30099779)
28. Takenaka K, Yoshimura A, Okano T, et al. Acute exacerbation of idiopathic interstitial pneumonia complicated by lung cancer, caused by treatment for lung cancer. Jpn JLung Cancer 1999;39:955-962 [Japanese]. (Pubitemid 30073568)
29. Hanibuchi M, Yamaguchi T, Okada T, et al. Clinical examination of acute exacerbation of idiopathic interstitial pneumonia (IIP) combined with lung cancer after anti-cancer treatment. Jpn J Lung Cancer 2001; 41:281-286 [Japanese]. (Pubitemid 32899583)
30. Isobe K, Hata Y, Sugino K, et al. Clinical characteristics of acute exacerbation of interstitial pneumonia associated with lung cancer after anti-cancer treatment. Jpn J Lung Cancer 2007;47:849-854 [Japanese]. (Pubitemid 351263017)
31. Kondoh Y, Nishiyama S, Ichikawa M, et al. Issues Concerning treatment of lung cancer patients with interstitial pneumonia: acute exacerbation of interstitial pneumonia. Jpn J Lung Cancer2008;48:732-736 [Japanese].
32. Kudoh S, Kato H, Nishiwaki Y, et al. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med 2008;177:1348-1357. (Pubitemid 351860912)
33. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006; 27:143-150. (Pubitemid 43092678)
34. Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005;128:1475-1482. (Pubitemid 41324435)
35. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-1047. (Pubitemid 40616955)
36. Sheppard MN, Harrison NK. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax 1992;47:1064-1074. (Pubitemid 23011028)
37. Fukushima K, Kawabata Y, Uchiyama T, et al. Prognosis of possible development into diffuse interstitial pneumonia for 127 patients with localized usual interstitial pneumonia. Nihon Kokyuuki Gakkai Zassi 1999;37:177-182 [Japanese].